Scholarlink

Asthma or COPD admissions are somewhat less impressive. Put them on inhalers and wish for the best, then majority of them get better. However, if they don’t improve <48 h, then you should know what to do next. Both asthma and COPD, the new mgmt guideline asks us to use biomarkers. For COPD, then mMRC or CAT to categorize patient by GOLD group. Elderly patient with COPD or asthma, consider ACO. Use prognostic predictors for COPD, such as ADO, BODE, DOSE.

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Asthma/COPD

  • 章节

  • 发表日期：

    2025年

查看全文
  • Masahiro J Morikawa

摘要

Asthma or COPD admissions are somewhat less impressive. Put them on inhalers and wish for the best, then majority of them get better. However, if they don’t improve <48 h, then you should know what to do next. Both asthma and COPD, the new mgmt guideline asks us to use biomarkers. For COPD, then mMRC or CAT to categorize patient by GOLD group. Elderly patient with COPD or asthma, consider ACO. Use prognostic predictors for COPD, such as ADO, BODE, DOSE.